Use of genetically engineered biological agents for the treatment of rheumatoid arthritis: general characteristics (a lecture)
Saved in:
| Main Authors: | Evgeni Lvovich Nasonov, D E Karateev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2013-04-01
|
| Series: | Научно-практическая ревматология |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/783 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
USE OF THE NEW GENETIC ENGINEERING BIOLOGICAL AGENT TOCILIZUMABIN THE TREATMENT OF RHEUMATOID ARTHRITIS
by: E L Nasonov, et al.
Published: (2010-03-01) -
Safety of using genetic engineering biological agents in rheumatoid arthritis
by: N V Chichasova, et al.
Published: (2010-03-01) -
EULAR RECOMMENDATIONS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS – 2013: GENERAL CHARACTERISTICS AND DISPUTABLE PROBLEMS
by: Evgenii Lvovich Nasonov, et al.
Published: (2014-02-01) -
PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS IN THE 21st CENTURY: FOCUS ON RITUXIMAB
by: Evgeni Lvovich Nasonov
Published: (2009-12-01) -
Rheumatoid arthritis therapy with genetically engineered biological agents in the Republic of Karelia
by: Irina Mikhailovna Marusenko
Published: (2013-12-01)